anti-CCL19 (CCL19) 抗体产品概述

Full name:
anti-Chemokine (C-C Motif) Ligand 19 抗体 (CCL19)
在www.antibodies-online.cn可供153 Chemokine (C-C Motif) Ligand 19 (CCL19) 抗体的17不同的供货商。 再加上,我们可以发CCL19 试剂盒 (70)CCL19 蛋白 (56)和数多这个蛋白质的别的产品。 总共280 CCL19产品已列进来了。
CCL19, CKb11, ELC, exodus-3, MIP-3b, MIP3B, Scya19, Scya19-ps1, Scya19-ps2, Scya19-ps3
列出全部抗体 基因 基因ID UniProt
CCL19 362506  
CCL19 65957  
CCL19 6363 Q99731



最受欢迎的抗anti-CCL19 (CCL19) 抗体


抗Rat (Rattus) CCL19 抗体:

抗Mouse (Murine) CCL19 抗体:

抗Human CCL19 抗体:

所有可销售的anti-CCL19 抗体


引用最多的anti-CCL19 抗体

  1. Human Monoclonal CCL19 Primary Antibody for FACS, ICC - ABIN4899709 : Berrih-Aknin, Ruhlmann, Bismuth, Cizeron-Clairac, Zelman, Shachar, Dartevelle, de Rosbo, Le Panse: CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. in Annals of neurology 2009 (PubMed)
    Show all 4 references for 4899709

  2. Human Polyclonal CCL19 Primary Antibody for IF (p), IHC (p) - ABIN740505 : Borrelli, Abrão, Taube, Darb-Esfahani, Köhler, Kaufmann, Chiantera, Mechsner: Immunohistochemical Investigation of Metastasis-Related Chemokines in Deep-Infiltrating Endometriosis and Compromised Pelvic Sentinel Lymph Nodes. in Reproductive sciences (Thousand Oaks, Calif.) 2015 (PubMed)


Mouse (Murine) Chemokine (C-C Motif) Ligand 19 (CCL19) interaction partners

  1. The beneficial effects of epicatechin in ameriorating diet-induced obesity and insulin (显示 INS 抗体) resistance could be mediated, at least in part, by marked suppression of CCL19 expression.

  2. Results suggest that baicalin exerts an inhibitory effect on airway inflammation, and this effect may be associated with the inhibition of CCR7 (显示 CCR7 抗体) and its ligands, CCL19 and CCL21 (显示 CCL21 抗体), as well as on the nuclear factor-Kappa B (NF-kappaB (显示 NFKB1 抗体)) pathway in a mouse model of asthma.

  3. Ccl19 protein

  4. Interferon-gamma (IFN-gamma (显示 IFNG 抗体)) and interleukin-12 (IL-12 (显示 IL12A 抗体)) levels in the tumors and plasma were significantly enhanced after processing with recombinant mouse CCL19.

  5. Modulation of the chemokines CCL19 and CCL21 (显示 CCL21 抗体) represents a potent immunoregulatory treatment approach, and thus represents a novel therapeutic target to stabilize atherosclerotic lesions.

  6. CCL19 (ELC) improves TH1 (显示 HAND1 抗体)-polarized immune responses and protective immunity in a murine Her2/neu (显示 ERBB2 抗体) DNA vaccination model.

  7. study shows that CCL19/21 and its possible signaling through CXCR3 (显示 CXCR3 抗体) are required for the development of thymic metallophilic macrophages

  8. CCL19 and CCL21 (显示 CCL21 抗体) induce prompt Ab responses to antigen, and negatively regulate helper T cell responses in vivo.

  9. CCX-CKR (显示 CCRL1 抗体)(-/-) have a 5-fold increase in the level of CCL21 (显示 CCL21 抗体) protein in blood, and 2- to 3-fold increases in CCL19 and CCL21 (显示 CCL21 抗体) in peripheral lymph nodes.

  10. Complete deficiency of CCL19 & CCL21 (显示 CCL21 抗体) but not CCL19 alone was associated with abnormal frequencies & localization of DC in naive lymph nodes. CCL19 was not required for DC migration from the skin, full DC maturation or efficient T-cell priming.

Human Chemokine (C-C Motif) Ligand 19 (CCL19) interaction partners

  1. findings connect NOTCH1 (显示 NOTCH1 抗体), DUSP22 (显示 DUSP22 抗体), and CCL19-driven chemotaxis within a single functional network, suggesting that modulation of the homing process may provide a relevant contribution to the unfavorable prognosis associated with NOTCH1 (显示 NOTCH1 抗体) mutations in CLL.

  2. Deletion of this extended C-terminus reduces CCL21 (显示 CCL21 抗体)'s affinity for heparin and transferring the CCL21 (显示 CCL21 抗体) C-terminus to CCL19 enhances heparin binding mainly through non-specific, electrostatic interactions

  3. CCL19 is significantly overexpressed in patients with unstable carotid atherosclerotic plaques and may be a possible novel biomarker for identifying high-risk patients in whom more urgent intervention may be indicated.

  4. CrkL (显示 CRKL 抗体) regulates CCL19 and CCR7 (显示 CCR7 抗体)-induced epithelial-to-mesenchymal transition via ERK (显示 EPHB2 抗体) signaling pathway in epithelial ovarian carcinoma patients.

  5. observed significantly higher concentrations of IL-8 (显示 IL8 抗体) (p < 0.001), MCP-1 (显示 CCL2 抗体) (p = 0.014), and MIP (显示 TNPO1 抗体)-3beta (p = 0.022) in the PF of women with endometriosis than in the controls.

  6. The solution structure of CCL19 is reported. It contains a canonical chemokine (显示 CCL1 抗体) domain. Chemical shift mapping shows the N-termini of PSGL-1 (显示 SELPLG 抗体) and CCR7 (显示 CCR7 抗体) have overlapping binding sites for CCL19 and binding is competitive.

  7. Our findings serve to elucidate the molecular mechanisms underlying the resistin (显示 RETN 抗体) induction of CCL19 expression in ECs and the shear-stress protection against this induction.

  8. The mRNA levels of CCL19/CCL21 (显示 CCL21 抗体) in ankylosing spondylitis hip ligament were significantly higher than in osteoarthritis ligament.

  9. Serum CCL19 and CCL21 (显示 CCL21 抗体) were up-regulated during Rickettsia conorii infection.

  10. CCL19 promoted monocyte adhesion to HUVEC cells. CCL19 rs2227302 was associated with coronary artery disease in a Chinese Han population.

CCL19 抗原简介

Antigen Summary

This gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. It specifically binds to chemokine receptor CCR7.

Alternative names and synonyms associated with CCL19

  • chemokine (C-C motif) ligand 19 (Ccl19) 抗体
  • chemokine (C-C motif) ligand 19, pseudogene 1 (Ccl19-ps1) 抗体
  • chemokine (C-C motif) ligand 19, pseudogene 2 (Ccl19-ps2) 抗体
  • chemokine (C-C motif) ligand 19, pseudogene 3 (Ccl19-ps3) 抗体
  • chemokine (C-C motif) ligand 19 (CCL19) 抗体
  • chemokine (C-C motif) ligand 19 (ccl19) 抗体
  • CCL19 抗体
  • CKb11 抗体
  • ELC 抗体
  • exodus-3 抗体
  • MIP-3b 抗体
  • MIP3B 抗体
  • Scya19 抗体
  • Scya19-ps1 抗体
  • Scya19-ps2 抗体
  • Scya19-ps3 抗体

Protein level used designations for CCL19

C-C motif chemokine 19 , chemokine (C-C motif) ligand 19 , CCL19 chemokine , CC chemokine ligand 19 , small inducible cytokine A19 , chemokine CCL19/MIP-3BETA , CK beta-11 , EBI1 ligand chemokine , EBI1-ligand chemokine , MIP-3-beta , beta chemokine exodus-3 , beta-chemokine exodus-3 , epstein-Barr virus-induced molecule 1 ligand chemokine , exodus-3 , macrophage inflammatory protein 3 beta , macrophage inflammatory protein 3-beta , small inducible cytokine subfamily A (Cys-Cys), member 19 , small-inducible cytokine A19 , EBI-1 ligand chemokine , EBV-induced molecule 1 ligand chemokine , chemokine CCL19

362506 Rattus norvegicus
65957 Mus musculus
65958 Mus musculus
65959 Mus musculus
427406 Gallus gallus
494464 Sus scrofa
100505409 Takifugu rubripes
448793 Canis lupus familiaris
473220 Pan troglodytes
509167 Bos taurus
574386 Macaca mulatta
6363 Homo sapiens
24047 Mus musculus
anti-CCL19 (CCL19) 抗体 精选生产商